Opinion|Videos|May 21, 2024
Collaborative Care: Key Stakeholders in HE Treatment and Recovery
Panelists highlight the significance of obtaining leadership buy-in and involving all care team members, while also sharing strategies for coordinating care effectively across the entire team.
Advertisement
Episodes in this series
Advertisement
Related to this article
Convenience should not replace connection.
Treated patients also had fewer post-acute hospitalizations and deaths, but individuals without risk factors saw no benefit.
A pharmacy technician reflects on 3 patient encounters that reshaped his
understanding of what a real patient requires.
In a Korean cohort of 1861 patients with nondialysis CKD, intake below 0.6 g/kg/d was linked to more kidney failure and higher all-cause mortality.
Doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd (Voceryq) targets HPV-6 and HPV-11 to reduce the surgical burden for adults with the rare airway disease.
Caitlin McClain, a nurse and Clostridioides difficile infection (CDI) survivor, says pharmacists are well placed to help patients tell routine antibiotic adverse effects apart from CDI, which could lead to earlier diagnosis.
A disease-modifying therapy for stage 3 T1D, a second once-weekly insulin, and automated insulin delivery for T2D mark a busy year in diabetes care.
Before lung cancer therapy begins, diagnostic findings and treatment readiness shape care, creating opportunities for pharmacists to help patients start safely.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Very Low Protein Intake Tied to Higher Kidney Failure Risk in CKD
2
Community Pharmacists Guide Patients New to Glucose Monitoring
3
FDA Grants Accelerated Approval to First Plasmid DNA-Based Immunotherapy for Recurrent Respiratory Papillomatosis
4
Caitlin McClain, Peggy Lillis Foundation Board Member, Shares Her Experience With C difficile
5